Skip to content
10-Q

Quarterly Report

LENZ THERAPEUTICS, INC. LENZ

0001815776-25-000071

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 31.29M sh
Shares Diluted Q3 2025 · Sep 30, 2025 28.54M sh
Shares Diluted Q3 2025 · Sep 30, 2025 28.05M sh
Shares Diluted Q3 2025 · Sep 30, 2024 27.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 19.2M sh
Capex Q3 2025 · Sep 30, 2025 $789K
Capex Q3 2025 · Sep 30, 2024 $319K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$36.15M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$50.31M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $25.4M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $20.16M
Stockholders Equity Q3 2025 · Sep 30, 2025 $193.93M
Stockholders Equity Q3 2025 · Jun 30, 2025 $206.37M
Stockholders Equity Q3 2025 · Mar 31, 2025 $192.01M
Stockholders Equity Q3 2025 · Dec 31, 2024 $204.08M
Stockholders Equity Q3 2025 · Sep 30, 2024 $215.28M
Stockholders Equity Q3 2025 · Jun 30, 2024 $192.92M
Stockholders Equity Q3 2025 · Mar 31, 2024 $198.17M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$92.71M
Current Liabilities Q3 2025 · Sep 30, 2025 $16.32M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.41M
Total Liabilities Q3 2025 · Sep 30, 2025 $16.78M
Total Liabilities Q3 2025 · Dec 31, 2024 $11.22M
Current Assets Q3 2025 · Sep 30, 2025 $207M
Current Assets Q3 2025 · Dec 31, 2024 $211.92M
Total Assets Q3 2025 · Sep 30, 2025 $210.7M
Total Assets Q3 2025 · Dec 31, 2024 $215.3M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.59
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.65
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.93
Eps Basic Q3 2025 · Sep 30, 2025 −$0.59
Eps Basic Q3 2025 · Sep 30, 2025 −$1.65
Eps Basic Q3 2025 · Sep 30, 2024 −$0.38
Eps Basic Q3 2025 · Sep 30, 2024 −$1.93
Sga Expense Q3 2025 · Sep 30, 2025 $27.6M
Sga Expense Q3 2025 · Sep 30, 2025 $51.51M
Sga Expense Q3 2025 · Sep 30, 2024 $6.49M
Sga Expense Q3 2025 · Sep 30, 2024 $19.45M
Rd Expense Q3 2025 · Sep 30, 2025 $3.79M
Rd Expense Q3 2025 · Sep 30, 2025 $18.67M
Rd Expense Q3 2025 · Sep 30, 2024 $6.45M
Rd Expense Q3 2025 · Sep 30, 2024 $23.93M
Net Income Q3 2025 · Sep 30, 2025 −$16.7M
Net Income Q3 2025 · Sep 30, 2025 −$46.23M
Net Income Q3 2025 · Jun 30, 2025 −$14.91M
Net Income Q3 2025 · Mar 31, 2025 −$14.62M
Net Income Q3 2025 · Sep 30, 2024 −$10.22M
Net Income Q3 2025 · Sep 30, 2024 −$37.12M
Net Income Q3 2025 · Jun 30, 2024 −$10.25M
Net Income Q3 2025 · Mar 31, 2024 −$16.65M
Operating Income Q3 2025 · Sep 30, 2025 −$18.89M
Operating Income Q3 2025 · Sep 30, 2025 −$52.68M
Operating Income Q3 2025 · Sep 30, 2024 −$12.95M
Operating Income Q3 2025 · Sep 30, 2024 −$43.39M